vs
Side-by-side financial comparison of AlTi Global, Inc. (ALTI) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
AlTi Global, Inc. is the larger business by last-quarter revenue ($86.6M vs $76.2M, roughly 1.1× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -15.1%, a 22.5% gap on every dollar of revenue. On growth, AlTi Global, Inc. posted the faster year-over-year revenue change (87.0% vs 25.5%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $-52.2M). Over the past eight quarters, AlTi Global, Inc.'s revenue compounded faster (30.6% CAGR vs 22.7%).
Cristal Global is the world's second-largest producer of titanium dioxide and a leading producer of titanium chemicals. It was formed when The National Titanium Dioxide Company Ltd. combined with Millennium Chemicals. The headquarters are in Jeddah, Saudi Arabia. It is a significant shareholder in Bemax, the world’s 5th largest TiO2 feedstock producer.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
ALTI vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.6M | $76.2M |
| Net Profit | $-13.1M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | -2.1% | 11.0% |
| Net Margin | -15.1% | 7.4% |
| Revenue YoY | 87.0% | 25.5% |
| Net Profit YoY | 75.6% | 30.7% |
| EPS (diluted) | — | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.6M | $76.2M | ||
| Q3 25 | $57.2M | $71.9M | ||
| Q2 25 | $53.1M | $63.1M | ||
| Q1 25 | $58.0M | $59.1M | ||
| Q4 24 | $46.3M | $60.7M | ||
| Q3 24 | $51.8M | $58.0M | ||
| Q2 24 | $49.5M | $55.0M | ||
| Q1 24 | $50.8M | $50.6M |
| Q4 25 | $-13.1M | $5.6M | ||
| Q3 25 | $-84.1M | $3.5M | ||
| Q2 25 | $-24.4M | $3.2M | ||
| Q1 25 | $1.9M | $2.6M | ||
| Q4 24 | $-53.8M | $4.3M | ||
| Q3 24 | $-72.5M | $3.9M | ||
| Q2 24 | $-6.4M | $1.5M | ||
| Q1 24 | $29.7M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | -2.1% | 11.0% | ||
| Q3 25 | -49.8% | 7.8% | ||
| Q2 25 | -56.7% | 8.1% | ||
| Q1 25 | -23.3% | 6.5% | ||
| Q4 24 | -42.7% | 10.6% | ||
| Q3 24 | -18.4% | 9.7% | ||
| Q2 24 | -30.2% | 6.6% | ||
| Q1 24 | -28.9% | 4.4% |
| Q4 25 | -15.1% | 7.4% | ||
| Q3 25 | -147.0% | 4.9% | ||
| Q2 25 | -45.9% | 5.0% | ||
| Q1 25 | 3.3% | 4.4% | ||
| Q4 24 | -116.1% | 7.1% | ||
| Q3 24 | -140.0% | 6.7% | ||
| Q2 24 | -12.9% | 2.7% | ||
| Q1 24 | 58.4% | 3.2% |
| Q4 25 | — | $0.14 | ||
| Q3 25 | — | $0.09 | ||
| Q2 25 | $-0.33 | $0.08 | ||
| Q1 25 | $-0.04 | $0.06 | ||
| Q4 24 | $-0.71 | $0.10 | ||
| Q3 24 | $-0.88 | $0.10 | ||
| Q2 24 | $-0.18 | $0.04 | ||
| Q1 24 | $0.18 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.2M | $13.5M |
| Total DebtLower is stronger | $883.0K | — |
| Stockholders' EquityBook value | $600.1M | $141.5M |
| Total Assets | $1.2B | $199.2M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $41.2M | $13.5M | ||
| Q3 25 | $35.8M | $11.1M | ||
| Q2 25 | $42.4M | $20.0M | ||
| Q1 25 | $52.8M | $10.2M | ||
| Q4 24 | $64.4M | $17.5M | ||
| Q3 24 | $220.6M | $11.3M | ||
| Q2 24 | $60.0M | $8.8M | ||
| Q1 24 | $134.2M | $7.3M |
| Q4 25 | $883.0K | — | ||
| Q3 25 | $586.0K | — | ||
| Q2 25 | $673.0K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $128.4M | — | ||
| Q2 24 | $164.0M | — | ||
| Q1 24 | $183.7M | — |
| Q4 25 | $600.1M | $141.5M | ||
| Q3 25 | $607.2M | $133.6M | ||
| Q2 25 | $685.4M | $139.7M | ||
| Q1 25 | $665.2M | $134.8M | ||
| Q4 24 | $658.4M | $131.4M | ||
| Q3 24 | $707.0M | $125.0M | ||
| Q2 24 | $540.2M | $119.4M | ||
| Q1 24 | $510.9M | $116.3M |
| Q4 25 | $1.2B | $199.2M | ||
| Q3 25 | $1.2B | $202.4M | ||
| Q2 25 | $1.2B | $184.6M | ||
| Q1 25 | $1.2B | $178.1M | ||
| Q4 24 | $1.3B | $177.1M | ||
| Q3 24 | $1.4B | $169.5M | ||
| Q2 24 | $1.3B | $163.9M | ||
| Q1 24 | $1.3B | $154.9M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | 0.30× | — | ||
| Q1 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-51.4M | $18.4M |
| Free Cash FlowOCF − Capex | $-52.2M | $9.7M |
| FCF MarginFCF / Revenue | -60.3% | 12.7% |
| Capex IntensityCapex / Revenue | 0.9% | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-51.4M | $18.4M | ||
| Q3 25 | $-53.5M | $18.4M | ||
| Q2 25 | $-19.9M | $12.3M | ||
| Q1 25 | $-30.2M | $2.9M | ||
| Q4 24 | $-50.7M | $15.0M | ||
| Q3 24 | $-4.9M | $12.7M | ||
| Q2 24 | $-30.2M | $10.2M | ||
| Q1 24 | $-15.5M | $1.2M |
| Q4 25 | $-52.2M | $9.7M | ||
| Q3 25 | — | $10.7M | ||
| Q2 25 | $-20.0M | $4.1M | ||
| Q1 25 | $-31.0M | $-12.6M | ||
| Q4 24 | $-58.2M | $3.2M | ||
| Q3 24 | $-9.4M | $1.7M | ||
| Q2 24 | $-31.2M | $1.2M | ||
| Q1 24 | $-15.7M | $-4.8M |
| Q4 25 | -60.3% | 12.7% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | -37.6% | 6.5% | ||
| Q1 25 | -53.4% | -21.4% | ||
| Q4 24 | -125.7% | 5.2% | ||
| Q3 24 | -18.2% | 3.0% | ||
| Q2 24 | -63.2% | 2.3% | ||
| Q1 24 | -30.9% | -9.5% |
| Q4 25 | 0.9% | 11.5% | ||
| Q3 25 | 0.0% | 10.6% | ||
| Q2 25 | 0.0% | 12.9% | ||
| Q1 25 | 1.3% | 26.2% | ||
| Q4 24 | 16.3% | 19.5% | ||
| Q3 24 | 8.7% | 19.0% | ||
| Q2 24 | 2.2% | 16.3% | ||
| Q1 24 | 0.4% | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | -15.80× | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | -0.52× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALTI
| Management Advisory Fees | $51.1M | 59% |
| Other | $32.7M | 38% |
| Distributions From Investments | $2.9M | 3% |
VMD
Segment breakdown not available.
